{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:23:02Z","timestamp":1791062582784,"version":"4.1.0"},"reference-count":35,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Studying the incidence of Kaposi sarcoma in relation to key variables can guide targeted research and subtype-specific clinical interventions. We reviewed the records of all patients who visited our hospital\u2019s dermatology outpatient clinic, and patients who were clinically and histopathologically diagnosed with Kaposi sarcoma were included in the study. The age, gender, lesion location, anti-HIV test results, and comorbidities of the patients were recorded. Thirty-three patients with Kaposi sarcoma were identified. The male\/female ratio was 2.7:1. The Kaposi sarcoma lesions were statistically significantly more prevalent in the lower extremities of HIV-negative patients (p = 0.005). Receiver operating characteristic (ROC) curve analysis identified 59 years as the optimal age cutoff for distinguishing between HIV-positive and HIV-negative patients. Anti-HIV positivity was significantly higher in individuals aged 59 and younger compared to those aged 60 and older (p &lt; 0.001). To the best of our knowledge, this is the first study to demonstrate a statistically significant higher prevalence of lower extremity lesions among HIV-negative patients and to identify 59 years as the optimal age cutoff for distinguishing between HIV-positive and HIV-negative Kaposi sarcoma patients using ROC curve analysis. The age-related patterns observed in this study warrant further investigation.<\/jats:p>","DOI":"10.3390\/v18010144","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:41:34Z","timestamp":1769164894000},"page":"144","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Kaposi Sarcoma: Retrospective Clinical Analysis with a Focus on Age and HIV Serostatus"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0963-271X","authenticated-orcid":false,"given":"Zuhal","family":"Er\u00e7in","sequence":"first","affiliation":[{"name":"Department of Dermatology, Sultan Abdulhamid Han Training and Research Hospital, University of Health Sciences, Istanbul 34668, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehtap","family":"Toprak","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sultan Abdulhamid Han Training and Research Hospital, University of Health Sciences, Istanbul 34668, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"ref_1","first-page":"138.1","article-title":"Kaposi Sarcoma","volume":"Volume 4","author":"Griffiths","year":"2024","journal-title":"Rook\u2019s Textbook of Dermatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e2024113","DOI":"10.5826\/dpc.1402a113","article-title":"Bullous Kaposi Sarcoma: An Uncommon Blistering Variant in an HIV-Negative Patient","volume":"14","author":"Gherardi","year":"2024","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1159\/000532114","article-title":"Kaposi Sarcoma of the Nail Unit: A Case Report and Review of the Literature","volume":"9","author":"Krygier","year":"2023","journal-title":"Skin. Appendage Disord."},{"key":"ref_4","first-page":"892","article-title":"S1 Guidelines for the Kaposi Sarcoma","volume":"20","author":"Esser","year":"2022","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/ced.13605","article-title":"Evolution of Kaposi sarcoma in the past 30 years in a tertiary hospital of the European Mediterranean basin","volume":"44","author":"Marcoval","year":"2019","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/00313020120083000","article-title":"The emerging role of the human herpesvirus 8 (HHV8) in human neoplasia","volume":"33","author":"Hong","year":"2001","journal-title":"Pathology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e35552","DOI":"10.1097\/MD.0000000000035552","article-title":"A retrospective study of Kaposi\u2019s sarcoma in Hotan region of Xinjiang, China","volume":"102","author":"Yang","year":"2023","journal-title":"Medicine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF03033698","article-title":"Kaposi\u2019s sarcoma: Clinico-pathological analysis of human immunodeficiency virus (HIV) and non-HIV associated cases","volume":"8","author":"Hong","year":"2002","journal-title":"Pathol. Oncol. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e1566","DOI":"10.1016\/S2214-109X(23)00349-2","article-title":"Global patterns and trends in Kaposi sarcoma incidence: A population-based study","volume":"11","author":"Fu","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/ijd.14563","article-title":"Kaposi sarcoma in Southern Finland (2006\u20132018)","volume":"58","author":"Kluger","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chalya, P.L., Mbunda, F., Rambau, P.F., Jaka, H., Masalu, N., Mirambo, M., Mushi, M.F., and Kalluvya, S.E. (2015). Kaposi\u2019s sarcoma: A 10-year experience with 248 patients at a single tertiary care hospital in Tanzania. BMC Res. Notes, 8.","DOI":"10.1186\/s13104-015-1348-9"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1111\/jocd.14549","article-title":"New-onset cutaneous kaposi\u2019s sarcoma following SARS-CoV-2 infection","volume":"20","author":"Magri","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40001-021-00620-9","article-title":"Disseminated Kaposi sarcoma following COVID-19 in a 61-year-old Albanian immunocompetent man: A case report and review of the literature","volume":"26","author":"Gardini","year":"2021","journal-title":"Eur. J. Med. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdcr.2023.09.036","article-title":"Treatment of Kaposi sarcoma with intralesional cidofovir in an HIV-negative man","volume":"42","author":"Fenner","year":"2023","journal-title":"JAAD Case Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"102378","DOI":"10.1016\/j.pdpdt.2021.102378","article-title":"Photodynamic therapy of classic Kaposi\u2019s sarcoma with video-fluorescence control","volume":"35","author":"Shiryaev","year":"2021","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/lsm.23242","article-title":"Nodular Classic Kaposi\u2019s Sarcoma Treated With Neodymium-Doped Yttrium Aluminum Garnet Laser Delivered Through a Tilted Angle: Outcome and 12-Month Follow Up","volume":"52","author":"Nasca","year":"2020","journal-title":"Lasers Surg. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e2024201","DOI":"10.5826\/dpc.1403a201","article-title":"Topical Sirolimus 0.1% as Off-Label Treatment of Kaposi\u2019s Sarcoma","volume":"14","author":"Tancredi","year":"2024","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/ijd.15407","article-title":"Comparison between propranolol 2% cream versus timolol 0.5% gel for the treatment of Kaposi sarcoma","volume":"60","author":"Giorgio","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.5826\/dpc.1501a4737","article-title":"Propranolol: A Promising Therapeutic Avenue for Classic Kaposi Sarcoma","volume":"15","author":"Genedy","year":"2025","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/ccr3.3428","article-title":"Involution of classic Kaposi sarcoma lesions under acitretin treatment Kaposi sarcoma treated with acitretin","volume":"8","author":"Daadaa","year":"2020","journal-title":"Clin. Case Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/bjd\/ljaf090","article-title":"Rapid improvements in Kaposi sarcoma with metformin: A report of two cases","volume":"193","author":"Su","year":"2025","journal-title":"Br. J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e70294","DOI":"10.1002\/jmv.70294","article-title":"Modern Approach to Manage Patients With Kaposi Sarcoma","volume":"97","author":"Bettuzzi","year":"2025","journal-title":"J. Med. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kavak, E.E., and \u00dcr\u00fcn, Y. (2025). Classical Kaposi sarcoma: An insight into demographic characteristics and survival outcomes. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-14085-0"},{"key":"ref_24","first-page":"e77213","article-title":"A Retrospective Study on the Incidence of Kaposi Sarcoma in the United States From 1999 to 2020 Using the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research (CDC WONDER) Database","volume":"17","author":"Balasubramanian","year":"2025","journal-title":"Cureus"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000492112","article-title":"Retrospective Analysis of 91 Kaposi\u2019s Sarcoma Cases: A Single-Center Experience and Review of the Literature","volume":"234","author":"Yazici","year":"2018","journal-title":"Dermatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/ijd.14476","article-title":"Clinical features of Kaposi\u2019s sarcoma: Experience from a Taiwanese medical center","volume":"58","author":"Huang","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Grabar, S., and Costagliola, D. (2021). Epidemiology of Kaposi\u2019s Sarcoma. Cancers, 13.","DOI":"10.3390\/cancers13225692"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000492175","article-title":"Epidemiological and Clinical Patterns of Kaposi Sarcoma: A 16-Year Retrospective Cross-Sectional Study from Yaound\u00e9, Cameroon","volume":"234","author":"Tounouga","year":"2018","journal-title":"Dermatology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"The China PEACE Collaborative Group (2021). Association of age and blood pressure among 3.3 million adults: Insights from China PEACE million persons project. J. Hypertens., 39, 1143\u20131154.","DOI":"10.1097\/HJH.0000000000002793"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/1097-0142(19800315)45:6<1472::AID-CNCR2820450629>3.0.CO;2-A","article-title":"Association of Kaposi\u2019s sarcoma with second primary malignancies: Possible etiopathogenic implications","volume":"45","author":"Safai","year":"1980","journal-title":"Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1684\/ejd.2018.3288","article-title":"Coexistence of Kaposi\u2019s sarcoma and psoriasis: Is there a hidden relationship?","volume":"28","author":"Brambilla","year":"2018","journal-title":"Eur. J. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"80595","DOI":"10.18632\/oncotarget.19685","article-title":"Diabetes and risk of Kaposi\u2019s sarcoma: Effects of high glucose on reactivation and infection of Kaposi\u2019s sarcoma-associated herpesvirus","volume":"8","author":"Chang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_33","first-page":"136","article-title":"Kaposi Sarcoma in a Chronic Renal Failure Patient Treated by Hemodialysis","volume":"25","author":"Tugcu","year":"2016","journal-title":"Turk. Neph. Dial. Transplant."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5021\/ad.2013.25.4.475","article-title":"Kaposi sarcoma in a patient with chronic renal failure undergoing dialysis","volume":"25","author":"Lee","year":"2013","journal-title":"Ann. Dermatol."},{"key":"ref_35","first-page":"1","article-title":"Anergy and immunosuppression in patients with rheumatoid arthritis","volume":"28","year":"2021","journal-title":"Rev. Colomb. Reumatol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/1\/144\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:47:17Z","timestamp":1769165237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/1\/144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["v18010144"],"URL":"https:\/\/doi.org\/10.3390\/v18010144","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]}}}